A retrospective cohort observation even showed that proton beam radiotherapy (PBT) combined with anti-PD1/PD-L1 provides a sustained and high rate of local tumor control in the irradiation field and an excellent systemic therapeutic effect, resulting in overall tumor control and survival (93). The gene discussed is CD274; the disease is neoplasm.